Atyr Pharma Inc. (ATYR)
NASDAQ · Healthcare
Atyr Pharma Inc. Operating Income 2019–2025
Atyr Pharma Inc. annual/quarterly operating income history and growth rate from 2019 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Atyr Pharma Inc. operating income for the quarter ending September 30, 2025 was -26.7 M, a 47.41% increase year-over-year.
- Atyr Pharma Inc. operating income for the twelve months ending September 30, 2025 was -81.0 M, a 34.68% increase year-over-year.
- Atyr Pharma Inc. annual operating income for 2025 was -77.6 M, a 14.30% increase from 2024.
- Atyr Pharma Inc. annual operating income for 2024 was -67.9 M, a 23.66% increase from 2023.
- Atyr Pharma Inc. annual operating income for 2023 was -54.9 M, a 18.35% increase from 2022.
- Atyr Pharma Inc. annual operating income for 2022 was -46.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Atyr Pharma Inc. Operating Income — FAQ
Atyr Pharma Inc. (ATYR) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Atyr Pharma Inc.'s operating income?
Atyr Pharma Inc. (ATYR) reported operating income of -$78M for fiscal 2025.
Where can I see ATYR's operating income history?
The chart and table above show Atyr Pharma Inc.'s operating income by year and by quarter, including the growth rate.